1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Overview
1.1 Product Overview and Scope of HIV Integrase Strand Transfer Inhibitors (INSTI)
1.2 Classification of HIV Integrase Strand Transfer Inhibitors (INSTI) by Types
1.2.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Comparison by Types (2020-2025)
1.2.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Types in 2018
1.2.3 Raltegravir
1.2.4 Elvitegravir Combination Drugs
1.2.5 Dolutegravir and Its Combination Drug
1.2.6 Bictegravir Combination Drug
1.2.7 Cabotegravir
1.2.8 Other
1.3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market by Application
1.3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size and Market Share Comparison by Applications (2015-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market by Regions
1.4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (Million USD) Comparison by Regions (2015-2025)
1.4.1 North America (USA, Canada and Mexico) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2015-2025)
1.4.2 Europe (Germany, France, UK, Russia and Italy) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2015-2025)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2015-2025)
1.4.4 South America (Brazil, Argentina, Colombia) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2015-2025)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) HIV Integrase Strand Transfer Inhibitors (INSTI) Status and Prospect (2015-2025)
1.5 Global Market Size of HIV Integrase Strand Transfer Inhibitors (INSTI) (2015-2025)
2 Manufacturers Profiles
2.1 Adcock Ingram Limited
2.1.1 Business Overview
2.1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.2 Affine Formulations Limited
2.2.1 Business Overview
2.2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.3 Aurobindo Pharma
2.3.1 Business Overview
2.3.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.4 Biocon Limited
2.4.1 Business Overview
2.4.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.5 Bristol-Myers Squibb
2.5.1 Business Overview
2.5.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.6 Cipla
2.6.1 Business Overview
2.6.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.7 Emcure Pharmaceuticals
2.7.1 Business Overview
2.7.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.8 Flamingo Pharmaceuticals Limited
2.8.1 Business Overview
2.8.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.9 Gilead Sciences
2.9.1 Business Overview
2.9.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.10 Hetero Drugs
2.10.1 Business Overview
2.10.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.11 IPCA Laboratories
2.11.1 Business Overview
2.11.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.12 Janssen Pharmaceutica (Johnson & Johnson)
2.12.1 Business Overview
2.12.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.13 LAURUS Labs
2.13.1 Business Overview
2.13.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.14 Medisist Pharma
2.14.1 Business Overview
2.14.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.15 Merck
2.15.1 Business Overview
2.15.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.16 Mylan
2.16.1 Business Overview
2.16.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.17 Ranbaxy Pharmaceuticals
2.17.1 Business Overview
2.17.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.18 Shanghai Desano Pharmaceuticals
2.18.1 Business Overview
2.18.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
2.19 ViiV Healthcare (GSK)
2.19.1 Business Overview
2.19.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2017-2019)
3 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Competition, by Players
3.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Share by Players (2015-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 HIV Integrase Strand Transfer Inhibitors (INSTI) Players Market Share
3.2.2 Top 10 HIV Integrase Strand Transfer Inhibitors (INSTI) Players Market Share
3.3 Market Competition Trend
4 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Regions
4.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Regions
4.2 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
4.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
4.4 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
4.5 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
4.6 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
5 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
5.1 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2015-2019)
5.2 USA HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
5.3 Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
5.4 Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
6 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
6.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2015-2019)
6.2 Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
6.3 UK HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
6.4 France HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
6.5 Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
6.6 Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
7 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
7.1 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2015-2019)
7.2 China HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
7.3 Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
7.4 Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
7.5 India HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
7.6 Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
8 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries
8.1 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2015-2019)
8.2 Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
8.3 Argentina HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
8.4 Colombia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
9 Middle East and Africa Revenue HIV Integrase Strand Transfer Inhibitors (INSTI) by Countries
9.1 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Countries (2015-2019)
9.2 Saudi Arabia HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
9.3 UAE HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
9.4 Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
9.5 Nigeria HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
9.6 South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Growth Rate (2015-2019)
10 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Type
10.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue and Market Share by Type (2015-2019)
10.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Type (2020-2025)
10.3 Raltegravir Revenue Growth Rate (2015-2025)
10.4 Elvitegravir Combination Drugs Revenue Growth Rate (2015-2025)
10.5 Dolutegravir and Its Combination Drug Revenue Growth Rate (2015-2025)
10.6 Bictegravir Combination Drug Revenue Growth Rate (2015-2025)
10.7 Cabotegravir Revenue Growth Rate (2015-2025)
10.8 Other Revenue Growth Rate (2015-2025)
11 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Segment by Application
11.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Application (2015-2019)
11.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Application (2020-2025)
11.3 Hospital Revenue Growth (2015-2019)
11.4 Clinic Revenue Growth (2015-2019)
11.5 Drug Center Revenue Growth (2015-2019)
11.6 Other Revenue Growth (2015-2019)
12 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast (2020-2025)
12.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast (2020-2025)
12.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast by Regions (2020-2025)
12.3 North America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2020-2025)
12.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2020-2025)
12.5 Asia-Pacific HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2020-2025)
12.6 South America HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2020-2025)
12.7 Middle East and Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Forecast (2020-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
